CCRAN

What CCRAN does

CCRAN (Colorectal Cancer Resource & Action Network) is a Canadian registered nonprofit charitable organization founded in 2006 by Filomena Servidio-Italiano following her father's death from metastatic cancer. Headquartered at 700-2 Bloor Street West, Toronto, Ontario, CCRAN delivers a tripartite "SEA" mission — Support, Education, and Advocacy — to colorectal cancer patients, caregivers, and the broader Canadian public. Its primary constituencies are colorectal cancer patients at any stage, family caregivers, young adult patients under 50 (an emerging segment with rising incidence in Canada), and at-risk individuals aged 50-74 who should be screened.

The organization's product portfolio centers on free digital self-serve tools delivered through its bilingual website (ccran.org): My CRC Consultant (a questionnaire-driven tool that generates personalized treatment-option reports for metastatic CRC patients to discuss with their oncologist), My CRC Coach (peer-to-peer support pairing), My Cancer Companion (a matching program using 19+ criteria to reduce post-diagnosis isolation), My Early Age Onset CRC Hub (resources for young patients), My CRC Treatment Side Effects (expert-reviewed side effect management), My Foods For Life (nutrition guidance), the Cancer Patient Empowerment Program, and monthly Research & Treatment Updates. In parallel, CCRAN operates physical/national-event assets including the Jumbo Colon (an inflatable walk-through colon exhibit available for $3,000/day or $3,500/two-day rental within the Quebec City–Windsor corridor) and three flagship annual conferences — the EAOC Symposium (5th annual in November 2025 with 500+ registrants, 70 speakers, 19 sessions), the Biomarkers Conference (4th annual in June 2025, pan-tumour precision oncology focus), and the My CRC Summit.

CCRAN's revenue model is donation- and sponsorship-driven rather than commercial: it accepts tax-deductible individual donations (monthly recurring, one-time, in memoriam, milestone, fundraiser — Charitable Registration Number 776821936RR0001), corporate sponsorships from oncology and genomics companies (Merck, AstraZeneca, Johnson & Johnson, Pfizer, Illumina, Incyte, Amgen, and others), and modest fee-for-service revenue from Jumbo Colon rentals and event partnerships. The organization employs 11-50 staff, is led by President & CEO Servidio-Italiano alongside a Chief Research Officer and Research Officer, and is governed by a Board of Directors plus a Medical & Scientific Advisory Board. Strategic alliances with seven cross-tumour patient advocacy organizations (Lung Cancer Canada, Canadian Breast Cancer Network, Pancreatic Cancer Canada, Prostate Cancer Foundation Canada, Young Adult Cancer Canada, My Gut Feeling, CHCC, Bladder Cancer Canada) extend its reach beyond colorectal cancer into broader precision-oncology and early-onset cancer advocacy.

Name

CCRAN

Legal name

Colorectal Cancer Resource & Action Network

Website

https://ccran.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

CCRAN is a Canadian nonprofit founded in 2006 that delivers Support, Education, and Advocacy for colorectal cancer patients, caregivers, and the public via free digital tools, peer-matching programs, national conferences, and the Jumbo Colon traveling exhibit, funded by donations and pharma sponsorships.

Ownership category

akta.pro rank

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations: CCRAN accepts various donation types including monthly recurring gifts, one-time gifts, in memoriam gifts, milestone/celebration gifts, and fundraiser/event gifts. Donations are tax-deductible (Charitable Registration Number 776821936RR0001).
2. Corporate Sponsorships: Pharmaceutical and healthcare companies sponsor CCRAN programs and events. Sponsors include Amgen, Bayer, Pfizer, Merck, AstraZeneca, Johnson & Johnson, Roche, Takeda, and others in the oncology space.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

CCRAN is a Canadian non-profit that provides free personalized support, education, and advocacy services to colorectal cancer patients and their caregivers. Its core offerings include one-on-one consultations, peer-to-peer coaching, caregiver companionship programs, condition-specific educational hubs, and nationwide educational events including conferences, symposia, and a traveling Jumbo Colon Exhibit for public awareness.

Product overview

CCRAN offers a comprehensive suite of patient-focused programs and services organized around three core pillars: Support, Education, and Advocacy (SEA). The portfolio consists primarily of digital tools and in-person programs rather than a unified software platform. Key digital offerings include My CRC Consultant (personalized treatment information), My CRC Coach (peer-to-peer support), My Cancer Companion (patient-companion matching), My Early Age Onset CRC Hub (young patient resources), My CRC Treatment Side Effects (side effect management), and My Foods For Life (nutritional guidance). Physical programs include the Jumbo Colon Exhibit (educational walk-through exhibit) and the Cancer Patient Empowerment Program. CCRAN also organizes major annual conferences including the Biomarkers Conference (precision oncology) and EAOC Symposium (early-onset cancer), along with the My CRC Summit and monthly Research & Treatment Updates. These offerings are provided as separate programs rather than an integrated platform with modules.

Differentiator

Problem solved

Functional benefit

Products and services

• My CRC Consultant

Quantifiable outcome

• 500+ registrants from across Canada and internationally at 2025 EAOC Symposium
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

15 partnerships are on record, tiered platinum, gold, bronze, silver and core.

• Merck CanadaplatinumOthers · 1 January 2025Platinum sponsor of CCRAN's Biomarkers Conference. Merck is a leading pharmaceutical company committed to advancing innovation in biomarkers and cancer research. Their support enables CCRAN to expand the conference and deliver a more impactful experience.
• AstraZeneca CanadagoldOthers · 1 January 2025Gold sponsor of CCRAN's Biomarkers Conference. AstraZeneca Canada supports advancing precision oncology and comprehensive genomic profiling initiatives.
• Johnson & JohnsongoldOthers · 1 January 2025Gold sponsor of CCRAN's Biomarkers Conference. J&J supports CCRAN's mission to advance biomarker testing and precision medicine in Canada.
• AmgenbronzeOthers · 1 January 2025Bronze sponsor of CCRAN's Biomarkers Conference. Amgen supports CCRAN's patient advocacy and education initiatives.
• Pfizer CanadasilverOthers · 1 January 2025Silver sponsor of CCRAN's Biomarkers Conference. Pfizer Canada supports advancing biomarker research and patient care.
• IlluminasilverTechnology or Integration · 1 January 2025Silver sponsor of CCRAN's Biomarkers Conference. Illumina provides genomic sequencing technology and supports comprehensive genomic profiling initiatives.
• IncytesilverOthers · 1 January 2025Silver sponsor of CCRAN's Biomarkers Conference. Incyte supports precision oncology research and patient advocacy.
• Lung Cancer CanadacoreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's Biomarkers Conference. Collaborates on advancing precision oncology and biomarker testing awareness across tumour types.
• Canadian Breast Cancer Network (CBCN)coreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's Biomarkers Conference. Works together on patient-centered cancer care initiatives.
• Pancreatic Cancer CanadacoreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's Biomarkers Conference. Supports shared goals of improving outcomes for cancer patients.
• Prostate Cancer Foundation CanadacoreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's Biomarkers Conference. Collaborates on advocacy and patient support initiatives.
• Young Adult Cancer Canada (YACC)coreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's EAOC Symposium. Focuses on young adult cancer patient needs and survivorship.
• My Gut Feeling - Stomach Cancer Foundation of CanadacoreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's conferences. Focuses on stomach cancer patient support and advocacy.
• Cholangio-Hepatocellular Carcinoma Canada (CHCC)coreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's EAOC Symposium. Addresses rare bile duct and liver cancers.
• Bladder Cancer CanadacoreStrategic or Co-development Partner · 1 January 2025Patient advocacy group partner in CCRAN's Biomarkers Conference. Supports bladder cancer patient community.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Market position

Weaknesses4 records

Competitive moat5 records

Customer concentration

• Xx.com/ccranorg
• YouTubeyoutube.com/@ccran_org
• Facebookfacebook.com/ccranorg
• LinkedInlinkedin.com/company/ccran
• Instagraminstagram.com/ccranorg
• Pinterestpinterest.com/ccranorg

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCRAN